PROFORMULA, LLC – Trademark Portfolio
Entity Type: 16
PROFORMULA, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include PROFORMULA. The owner is based in Cypress, TX.
11085 Regency Green Dr.
Cypress, TX 77429
Showing of trademarks Trademarks
Trademark Classifications
PROFORMULA, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does PROFORMULA, LLC have?
PROFORMULA, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned.
What trademark classes does PROFORMULA, LLC file in?
PROFORMULA, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 4 (Lubricants & Fuels), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are PROFORMULA, LLC's most well-known trademarks?
PROFORMULA, LLC's registered trademark portfolio includes well-known marks such as PROFORMULA. These are among 6 currently registered trademarks in the portfolio.
What is PROFORMULA, LLC's trademark registration success rate?
PROFORMULA, LLC has a 75% trademark registration rate, with 6 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.